In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan.
Gene Solutions is set to bring its cutting-edge NIPT tests (trademarked as triSure™) and oncology tests (SPOT-MAS early cancer detection, K-TRACK, K-4CARE comprehensive genomic profiling, ctDNA-MRD monitoring) to Taiwan, expanding its footprint in the APAC region. These innovative tests, trusted by millions across Asia, will soon be available to Taiwanese patients, offering unparalleled accuracy and reliability.
NEWCL, established in 2012 and part of DITECH Enterprise, is a premier biomedical laboratory located in New Taipei City. It serves major hospitals and medical service units across Taiwan, providing a wide range of bio testing services including HBV, HCV, Genotype, and Allergen Chip testing.
Combining Gene Solutions' expertise in NGS test development with NEWCL's robust laboratory capabilities, this partnership aims to create one of Taiwan's most advanced NGS laboratories. This facility will cater to the growing demand for sophisticated DNA testing in prenatal care and precision oncology, ensuring Taiwanese patients have access to the latest advancements in genetic testing.
With the anticipated launch of the partnered NGS lab and tech-transfer in 2025, both companies will explore the commercialisation of NGS testing in Taiwan through NEWCL's established commercial network, including TUNG-BO Medical Ltd. Gene Solutions, with its strong foundation in Molecular Biology Research and Genetic Counseling, will drive scientific conferences, medical training, and research collaborations with hospitals and medical service units across Taiwan.
